Pennylane, a French startup that sells accounting software, has raised €175 million ($204 million) in a funding round led by growth equity investor TCV.
Rev. Proc. 2026-08 updates procedures for exemption from income tax on a group basis for 501(c) organizations that are under the control of a central organization.
Biohaven has suffered a few setbacks in recent months, including an FDA rejection and a missed $150 million benchmark payment, but CEO Vlad Coric looked for the brighter side at JPM, specifically emphasizing a serendipitous discovery that could get the company in the obesity game.
The star of the acquisition, anti-IgE antibody ozureprubart, is being tested as a prophylactic treatment for food allergies, potentially setting up a competition for GSK with Roche’s Xolair.